Torrent Pharma Posts 30% YoY Rise in Q2 Net Profit on Strong Revenue Growth

💊

reported consolidated net profit of ₹5.9 billion, marking a 30% YoY increase from ₹4.53 billion. Revenue grew to ₹33 billion, up from ₹28.9 billion last year, supported by a strong performance across key therapeutic segments. EBITDA improved to ₹10.8 billion versus ₹9.4 billion YoY, while EBITDA margin expanded to 32.80% from 32.5%. The results reflect sustained demand momentum and continued operational efficiencies.